136 active trials 69 recruiting 2 Phase 3 32 disease areas 61 changes in 30 days
| Early Phase 1 | 7 | |
| Phase 1 | 24 | |
| Phase 1/2 | 9 | |
| Phase 2 | 54 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07357298 | Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer | Breast Cancer | Recruiting | 2026-05-15 |
| Phase 2/3 | ||||
| NCT03495427 | PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher… | Prostate Cancer | Recruiting | 2026-03-02 |
| Phase 2 | ||||
| NCT06350318 | Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas | Follicular Lymphoma | Recruiting | 2026-09-28 |
| NCT05528133 | Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer | Triple Negative Breast Cancer | Recruiting | 2026-09-25 |
| NCT06144606 | Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic… | B-Cell Lymphoblastic Leukemia | Recruiting | 2026-09-25 |
| NCT06553872 | Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R… | Mantle Cell Lymphoma | Recruiting | 2026-09-23 |
| NCT06745882 | Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/… | Non-small Cell Lung Cancer | Recruiting | 2026-09-21 |
| NCT05757219 | Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy | Diffuse Large B Cell Lymphoma | Recruiting | 2026-09-16 |
| NCT05115474 | Study of Screening Brain MRIs in Stage IV Breast Cancer | Triple Negative Breast Cancer | Recruiting | 2026-09-15 |
| NCT07686250 | Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery | Breast Cancer | Recruiting | 2026-09-15 |
| NCT06701812 | Digoxin Medulloblastoma Study | Medulloblastoma | Recruiting | 2026-08-26 |
| NCT06660355 | Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy | Chronic Graft-versus-host Disease (cGVHD) | Recruiting | 2026-08-05 |
| NCT07694986 | Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for… | Breast Cancer | Recruiting | 2026-07-10 |
| NCT06833502 | Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer | Breast Cancer | Recruiting | 2026-07-02 |
| NCT07476001 | Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC | Metastatic Castration-resistant Prostate Cancer | Recruiting | 2026-05-15 |
| NCT06760156 | Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym | Large B-cell Lymphoma | Recruiting | 2026-04-03 |
| NCT06137274 | Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC | Squamous Cell Carcinoma | Recruiting | 2026-04-01 |
| NCT06295159 | Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma | Melanoma Stage III | Recruiting | 2026-04-01 |
| NCT06553885 | Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC | Metastatic Colorectal Cancer | Recruiting | 2026-04-01 |
| NCT06660368 | BCL2i CLAG-M in R/R Acute Myeloid Leukemia | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Recruiting | 2026-04-01 |
| NCT07007273 | Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma | Cutaneous Sarcoma | Recruiting | 2026-04-01 |
| NCT06104592 | Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk… | Large B-cell Lymphoma | Recruiting | 2026-03-31 |
| NCT07276386 | Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal… | Metastatic Uveal Melanoma | Recruiting | 2026-03-31 |
| NCT05325632 | Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab &… | HER2-positive Breast Cancer | Recruiting | 2026-03-02 |
| NCT06511882 | Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD | Acute Myeloid Leukemia | Recruiting | 2026-02-27 |
Breast Cancer (18) · Melanoma (13) · Leukemia (12) · Lung Cancer (10) · Prostate Cancer (10) · Pancreatic Cancer (8) · Non-Small Cell Lung Cancer (NSCLC) (7) · Acute Myeloid Leukemia (AML) (6) · Non-Hodgkin Lymphoma (6) · Sarcoma (6)